Potent and selective cathepsin K inhibitors

被引：13

作者：

Shinozuka, Tsuyoshi

Shimada, Kousei

Matsui, Satoshi

Yamane, Takahiro

Ama, Mayumi

Fukuda, Takeshi

Taki, Motohiko

Takeda, Yuko

Otsuka, Eri

Yamato, Michiko

Mochizuki, Shin-ichi

Ohhata, Keiko

Naito, Satoru

机构：

[1] Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[2] Sankyo Co Ltd, Lead Discovery Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[3] Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2006年 / 14卷 / 20期

关键词：

cathepsin K; inhibitor; SAR study; OVX rat assay;

D O I：

10.1016/j.bmc.2006.06.032

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A novel series of cathepsin K inhibitors derived from Novartis compound I is described. Optimization of the P1, P3, and P1' units led to the identification of 4-aminophenoxyacetic acid 24b with an IC50 value of 4.8 nM, which possessed an excellent selectivity over other human cathepsins and good pharmacokinetic (PK) properties. Oral administration of compound 24b to ovariectomized (OVX) rats showed a trend toward an improvement of bone mineral density (BMD) in the femur bone. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：6789 / 6806

页数：18

共 50 条

[41] Cathepsin K inhibitors and antisclerostin antibodies. The next treatments for osteoporosis? [J].

Chapurlat, Roland .

JOINT BONE SPINE, 2016, 83 (03) :254-256

[42] Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors [J].

Silva, Taynara L. ;

dos Santos, Deborah A. ;

de Jesus, Hugo C. R. ;

Bromme, Dieter ;

Fernandes, Joao B. ;

Paixao, Marcio W. ;

Correa, Arlene G. ;

Vieira, Paulo C. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (15)

[43] Acyclic, orally bioavailable ketone-based cathepsin K inhibitors [J].

Barrett, David G. ;

Catalano, John G. ;

Deaton, David N. ;

Long, Stacey T. ;

McFadyen, Robert B. ;

Miller, Aaron B. ;

Miller, Larry R. ;

Samano, Vicente ;

Tavares, Francis X. ;

Wells-Knecht, Kevin J. ;

Wright, Lois L. ;

Zhou, Hui-Qlang Q. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) :22-27

[44] Highly potent inhibitors of cathepsin K with a differently positioned cyanohydrazide warhead: structural analysis of binding mode to mature and zymogen-like enzymes [J].

Benysek, Jakub ;

Busa, Michal ;

Rubesova, Petra ;

Fanfrlik, Jindrich ;

Lepsik, Martin ;

Brynda, Jiri ;

Matouskova, Zuzana ;

Bartz, Ulrike ;

Horn, Martin ;

Gutschow, Michael ;

Mares, Michael .

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) :515-526

[45] Enhancement of Inhibitory Activity by Combining Allosteric Inhibitors Putatively Binding to Different Allosteric Sites on Cathepsin K [J].

Sato, Shun ;

Yamamoto, Kana ;

Ito, Moeno ;

Nishino, Katsutoshi ;

Otsuka, Takanao ;

Irie, Kazuhiro ;

Nagao, Masaya .

MOLECULES, 2023, 28 (10)

[46] Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitors [J].

Thompson, SK ;

Halbert, SM ;

DesJarlais, RL ;

Tomaszek, TA ;

Levy, MA ;

Tew, DG ;

Ijames, CF ;

Veber, DF .

BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (04) :599-605

[47] The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K [J].

Gauthier, Jacques Yves ;

Chauret, Nathalie ;

Cromlish, Wanda ;

Desmarais, Sylvie ;

Duong, Le T. ;

Falgueyret, Jean-Pierre ;

Kimmel, Donald B. ;

Lamontagne, Sonia ;

Leger, Serge ;

LeRiche, Tammy ;

Li, Chun Sing ;

Masse, Frederic ;

Mckay, Daniel J. ;

Nicoll-Griffith, Deborah A. ;

Oballa, Renata A. ;

Palmer, James T. ;

Percival, M. David ;

Riendeau, Denis ;

Robichaud, Joel ;

Rodan, Gideon A. ;

Rodan, Sevgi B. ;

Seto, Carmai ;

Therien, Michel ;

Truong, Vouy-Linh ;

Venuti, Michael C. ;

Wesolowski, Gregg ;

Young, Robert N. ;

Zamboni, Robert ;

Black, W. Cameron .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) :923-928

[48] Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes [J].

Pajk, Stane ;

Knez, Damijan ;

Kosak, Urban ;

Zorovic, Maja ;

Brazzolotto, Xavier ;

Coquelle, Nicolas ;

Nachon, Florian ;

Colletier, Jacques-Philippe ;

Zivin, Marko ;

Stojan, Jure ;

Gobec, Stanislav .

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) :498-505

[49] Recent advance in the development of novel, selective and potent FGFR inhibitors [J].

Liu, Feng-Tao ;

Li, Nian-Guang ;

Zhang, Yan-Min ;

Xie, Wu-Chen ;

Yang, Si-Ping ;

Lu, Tao ;

Shi, Zhi-Hao .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186

[50] Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors [J].

Duron, Sergio G. ;

Lindstrom, Andrew ;

Bonnefous, Celine ;

Zhang, Hui ;

Chen, Xiaohong ;

Symons, Kent T. ;

Sablad, Marciano ;

Rozenkrants, Natasha ;

Zhang, Yan ;

Wang, Li ;

Yazdani, Nahid ;

Shiau, Andrew K. ;

Noble, Stewart A. ;

Rix, Peter ;

Rao, Tadimeti S. ;

Hassig, Christian A. ;

Smith, Nicholas D. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) :1237-1241

← 1 2 3 4 5 →